The Oncology Institute
TOI
29 hedge funds and large institutions have $159M invested in The Oncology Institute in 2022 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
38% more funds holding
Funds holding: 21 → 29 (+8)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
0.48% more ownership
Funds ownership: 28.31% → 28.79% (+0.48%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
21% less capital invested
Capital invested by funds: $200M → $159M (-$41.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.67M |
| 2 |
Millennium Management
New York
|
+$1.08M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
+$511K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$467K |
| 5 |
State Street
Boston,
Massachusetts
|
+$210K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AGM
Alpine Global Management
New York
|
-$2.32M |
| 2 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.95M |
| 3 |
EAM
Empery Asset Management
New York
|
-$872K |
| 4 |
Goldman Sachs
New York
|
-$716K |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$577K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $4K | +$3.91K | +579 | New |
|
27
JP Morgan Chase
New York
| $3K | -$22.9K | -3,400 | -89% |
|
|
AGM
28
Alpine Global Management
New York
| $292 | -$2.32M | -344,037 | -89% |
|
|
CH
29
CVI Holdings
Wilmington,
Delaware
| – | -$1.95M | -200,000 | Closed |
|
30
UBS Group
Zurich,
Switzerland
| – | -$18K | -1,859 | Closed |
|
31
Wells Fargo
San Francisco,
California
| – | +$432 | +64 | New |
|
TOI Hedge Fund Activity: Q1 2022 in Review
29 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in The Oncology Institute (TOI) for Q1 2022, worth a combined $159M — down 21% from $200M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TOI positions and 2 closed out — a net gain of 8 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.67M. The largest seller was Alpine Global Management, cutting an estimated $2.32M.
- 29 institutional investors held The Oncology Institute (TOI) as of Q1 2022, up from 21 in Q4 2021.
- Funds reported $159M of The Oncology Institute stock for Q1 2022, down 21% quarter-over-quarter.
- 10 funds opened new The Oncology Institute positions in Q1 2022 and 2 closed out, a net change of +8 holders.
- The largest The Oncology Institute buyer in Q1 2022 was Vanguard Group, an estimated $2.67M added.
- The largest The Oncology Institute seller in Q1 2022 was Alpine Global Management, an estimated $2.32M sold.
Based on aggregated 13F filings for Q1 2022.